“Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report”. 2024. Dermatology Practical & Conceptual 14 (4): e2024252. https://doi.org/10.5826/dpc.1404a252.